247 related articles for article (PubMed ID: 23291472)
1. Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function.
Schmidt IM; Hall IE; Kale S; Lee S; He CH; Lee Y; Chupp GL; Moeckel GW; Lee CG; Elias JA; Parikh CR; Cantley LG
J Am Soc Nephrol; 2013 Feb; 24(2):309-19. PubMed ID: 23291472
[TBL] [Abstract][Full Text] [Related]
2. The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury.
Sohn MH; Kang MJ; Matsuura H; Bhandari V; Chen NY; Lee CG; Elias JA
Am J Respir Crit Care Med; 2010 Oct; 182(7):918-28. PubMed ID: 20558631
[TBL] [Abstract][Full Text] [Related]
3. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.
Lee CG; Hartl D; Lee GR; Koller B; Matsuura H; Da Silva CA; Sohn MH; Cohn L; Homer RJ; Kozhich AA; Humbles A; Kearley J; Coyle A; Chupp G; Reed J; Flavell RA; Elias JA
J Exp Med; 2009 May; 206(5):1149-66. PubMed ID: 19414556
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 Associates with Renal Recovery in Deceased Donor Kidney Transplantation.
Puthumana J; Hall IE; Reese PP; Schröppel B; Weng FL; Thiessen-Philbrook H; Doshi MD; Rao V; Lee CG; Elias JA; Cantley LG; Parikh CR
J Am Soc Nephrol; 2017 Feb; 28(2):661-670. PubMed ID: 27451287
[TBL] [Abstract][Full Text] [Related]
5. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.
Hector A; Kormann MS; Mack I; Latzin P; Casaulta C; Kieninger E; Zhou Z; Yildirim AÖ; Bohla A; Rieber N; Kappler M; Koller B; Eber E; Eickmeier O; Zielen S; Eickelberg O; Griese M; Mall MA; Hartl D
PLoS One; 2011; 6(9):e24399. PubMed ID: 21949714
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.
Sakazaki Y; Hoshino T; Takei S; Sawada M; Oda H; Takenaka S; Imaoka H; Matsunaga K; Ota T; Abe Y; Miki I; Fujimoto K; Kawayama T; Kato S; Aizawa H
PLoS One; 2011; 6(9):e24177. PubMed ID: 21915293
[TBL] [Abstract][Full Text] [Related]
7. Donor kidney injury molecule-1 promotes graft recovery by regulating systemic necroinflammation.
Lee JY; Ismail OZ; Zhang X; Haig A; Lian D; Gunaratnam L
Am J Transplant; 2018 Aug; 18(8):2021-2028. PubMed ID: 29603641
[TBL] [Abstract][Full Text] [Related]
8. The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress.
Park JA; Drazen JM; Tschumperlin DJ
J Biol Chem; 2010 Sep; 285(39):29817-25. PubMed ID: 20650887
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the MAPK and PI3K pathways in chitinase 3-like 1-regulated hyperoxia-induced airway epithelial cell death.
Kim MN; Lee KE; Hong JY; Heo WI; Kim KW; Kim KE; Sohn MH
Biochem Biophys Res Commun; 2012 May; 421(4):790-6. PubMed ID: 22554524
[TBL] [Abstract][Full Text] [Related]
10. Tubular expression of KIM-1 does not predict delayed function after transplantation.
Schröppel B; Krüger B; Walsh L; Yeung M; Harris S; Garrison K; Himmelfarb J; Lerner SM; Bromberg JS; Zhang PL; Bonventre JV; Wang Z; Farris AB; Colvin RB; Murphy BT; Vella JP
J Am Soc Nephrol; 2010 Mar; 21(3):536-42. PubMed ID: 20019169
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of chitinase 3-like 1 in aorta of patients with atherosclerosis and suppression of atherosclerosis in apolipoprotein E-knockout mice by chitinase 3-like 1 gene silencing.
Gong Z; Xing S; Zheng F; Xing Q
Mediators Inflamm; 2014; 2014():905463. PubMed ID: 24729664
[TBL] [Abstract][Full Text] [Related]
12. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.
Zhou Y; Peng H; Sun H; Peng X; Tang C; Gan Y; Chen X; Mathur A; Hu B; Slade MD; Montgomery RR; Shaw AC; Homer RJ; White ES; Lee CM; Moore MW; Gulati M; Lee CG; Elias JA; Herzog EL
Sci Transl Med; 2014 Jun; 6(240):240ra76. PubMed ID: 24920662
[TBL] [Abstract][Full Text] [Related]
13. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts.
Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P
Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599
[TBL] [Abstract][Full Text] [Related]
14. Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema.
Matsuura H; Hartl D; Kang MJ; Dela Cruz CS; Koller B; Chupp GL; Homer RJ; Zhou Y; Cho WK; Elias JA; Lee CG
Am J Respir Cell Mol Biol; 2011 Jun; 44(6):777-86. PubMed ID: 20656949
[TBL] [Abstract][Full Text] [Related]
15. YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients.
Malyszko J; Koc-Zorawska E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2651-3. PubMed ID: 25380887
[TBL] [Abstract][Full Text] [Related]
16. Breast Regression Protein-39/Chitinase 3-Like 1 Promotes Renal Fibrosis after Kidney Injury
Montgomery TA; Xu L; Mason S; Chinnadurai A; Lee CG; Elias JA; Cantley LG
J Am Soc Nephrol; 2017 Nov; 28(11):3218-3226. PubMed ID: 28679671
[TBL] [Abstract][Full Text] [Related]
17. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation.
Jansen MPB; Pulskens WPC; Uil M; Claessen N; Nieuwenhuizen G; Standaar D; Hau CM; Nieuwland R; Florquin S; Bemelman FJ; Leemans JC; Roelofs JJTH
Nephrol Dial Transplant; 2020 Aug; 35(8):1320-1327. PubMed ID: 30590723
[TBL] [Abstract][Full Text] [Related]
18. RelB/p50 complexes regulate cytokine-induced YKL-40 expression.
Bhardwaj R; Yester JW; Singh SK; Biswas DD; Surace MJ; Waters MR; Hauser KF; Yao Z; Boyce BF; Kordula T
J Immunol; 2015 Mar; 194(6):2862-70. PubMed ID: 25681350
[TBL] [Abstract][Full Text] [Related]
19. Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.
Hu C; Li L; Ding P; Li L; Ge X; Zheng L; Wang X; Wang J; Zhang W; Wang N; Gu H; Zhong F; Xu M; Rong R; Zhu T; Hu W
J Immunol; 2018 Dec; 201(12):3717-3730. PubMed ID: 30429287
[TBL] [Abstract][Full Text] [Related]
20. Met activation is required for early cytoprotection after ischemic kidney injury.
Mason S; Hader C; Marlier A; Moeckel G; Cantley LG
J Am Soc Nephrol; 2014 Feb; 25(2):329-37. PubMed ID: 24136921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
